GoldBamboo.com - Knowledge is strong medicine
  

A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency - Article


  Not Signed In - Sign In / Register






Very long-chain acyl-coenzyme A dehydrogenase deficiency

ACADVL; acyl-CoA dehydrogenase very long chain deficiency; VLCAD deficiency; VLCAD-C; VLCAD-H


Clinical Trial: A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency

This study is currently recruiting patients.

Sponsored by: Walter Reed Army Institute of Research (WRAIR)
Information provided by: Walter Reed Army Institute of Research (WRAIR)

Purpose

This study will evaluate a new and safe testing method for identifying medicines that can cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are looking for volunteers with G6PD deficiency who would be willing to donate blood samples.

Condition Treatment or Intervention
Glucosephosphate Dehydrogenase Deficiency
Favism
 Drug: Primaquine

MedlinePlus related topics:  Anemia;   Food Contamination and Poisoning;   Genetic Disorders;   Metabolic Disorders;   Poisoning

Study Type: Interventional
Study Design: Prevention, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Pharmacodynamics Study

Further Study Details: 

Expected Total Enrollment:  14

Study start: December 2003

Eligibility

Ages Eligible for Study:  18 Years   -   60 Years,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

  • Not pregnant or planning pregnancy
  • Have not taken any anti-malarial medication in past month
  • Negative blood tests for HIV and specific types of hepatitis
  • Not allergic to primaquine
  • Need both G6PD-deficient volunteers and G6PD-normal volunteers

Location and Contact Information


Maryland
      Walter Reed Army Institute of Research, Silver Spring,  Maryland,  20910,  United States; Recruiting
Felicia L Breedy  866-856-3259    clinical2@na.amedd.army.mil 
Oman Q Salazar  866-856-3259    clinical2@na.amedd.army.mil 
In-Kyu Yoon, M.D.,  Principal Investigator

More Information

Recruitment page for G6PD study

Study ID Numbers:  G6PD; 992
Record last reviewed:  March 2004
Last Updated:  October 13, 2004
Record first received:  January 20, 2004
ClinicalTrials.gov Identifier:  NCT00076323
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Very long-chain acyl-coenzyme A dehydrogenase deficiency.

October 8, 2008



Page Updated: September 6, 2005
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.